Tumor Genomics Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2028

The global tumor genomics market is expected to reach a market size of 56.54 Billion by 2028

SURREY, BRITISH COLUMBIA, CANADA , March 28, 2022 /EINPresswire.com/ -- The latest research report by emergen research, named ‘Global tumor genomics market - Forecast to 2028’, entails a comprehensive review of the global Tumor Genomics market’s present and future trends. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue estimations over the forecast timeframe. The study is inclusive of a profound analysis of this business sphere focuses on the overall remuneration of the market over the projected period. The study also includes significant information pertinent to the Tumor Genomics industry, particularly the current COVID-19 scenario.Tumor is often caused by genetic alterations, including gene fusions, large chromosomal rearrangements; however, next generation sequencing techniques have helped researchers gather vast amounts of tumor genomic data and record genetic mutations in various cancer types.

Increasing number of cancer cases, rising government initiatives and projects, new drug developments, and increasing demand for cancer-specific diagnostics are factors driving global tumor genomic market growth.

Tumor Genomics Market Size – USD 21.42 Billion in 2020, Market Growth – at a CAGR of 12.8%, Market Trends – Next generation sequencing techniques and new drug discoveries.

Get a sample of the report : https://www.emergenresearch.com/request-sample/531

In September 2018, Cancer Genetics Inc. and NovellusDx Ltd. signed a merger agreement in order to combine their data associated to tumor anatomy. The aim behind the merger is to enhance and accelerate the therapeutic development to improve treatment success rates for companies. With the proprietary technology and machine learning technology of NovellusDX Ltd., Cancer Genetics aims to form a leading oncology-focused precision medicine company.

Biomarkers play an important role in the detection of cancer and it may be used to detect early cancer symptoms or to perform differential diagnosis of cancerous tumors.

Revenue from the tumor genomic market in Asia Pacific is expected to expand at a rapid CAGR during the forecast period. This can be attributed to rising government funding for cancer detection and awareness, and introduction of state-of-the-art research institutions.

Key players in genomic biomarkers are Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Pacific Biosciences of California, Inc., NeoGenomics Laboratories, Inc., Myriad Genetics, Inc., and PerkinElmer.

Radical Highlights of the Tumor Genomics Market Report:

Comprehensive overview of the Tumor Genomics market along with analysis of the changing dynamics of the market

Growth Assessment of various market segments throughout the forecast period

Regional and global analysis of the market players, including their market share and global position

Growth strategies adopted by key market players to combat the impact of the COVID-19 pandemic on the market

Impact of the technological developments and R&D advancements on the Tumor Genomics market

Information about profit-making strategies and developmental strategies of major companies and manufacturers

Insightful information for the new entrants willing to enter the market

Details and insights about business expansion strategies, product launches, and other collaborations

The report incorporates advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, feasibility analysis, and investment return analysis

Emergen Research has segmented the global tumor genomic market on the basis of technique, application, end-use, and region:

Technique Outlook (Revenue, USD Billion; 2021–2028)

Next Generation Sequencing Technique (NGS)

Polymerase Chain Reaction (PCR)

Microarray

In-Situ Hybridization (ISH)

Immunohistochemistry (ICH)

Others (Mass Spectrometry and Flow Cytometry)

Application Outlook (Revenue, USD Billion; 2021–2028)

Diagnostics and Monitoring

Drug Discovery and Development

Biomarker Discovery

End-use Outlook (Revenue, USD Billion; 2021–2028)

Academics and Research Organizations

Hospitals and Ambulatory Clinics

Clinical and Diagnostic Laboratories

Biotechnology and Pharmaceutical Company

Regional Analysis of the Tumor Genomics Market:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a discount on the report : https://www.emergenresearch.com/request-discount/531

Unfolding the prime factors prompting global market growth:

The study offers an in-depth analysis of the product outlook, which depicts the latest production growth trends and profit valuation. It further fragments the global Tumor Genomics market into a broad product spectrum.

A detailed description of the distribution channels, including distributors, producers, and buyers, is one of the report’s key market highlights.

The report strives to present the reader with deep insights of the market that can assist them in making fruitful business decisions and strategic investment plans. It highlights the lucrative investment opportunities and growth prospects to help key companies and new entrants capitalize on the emerging opportunities and gain a robust footing in the market.

The report further segments the market on the basis of product types and application spectrum offered in the market. The report also offers insights into the segment expected to show significant growth over the forecast period.

Key Objectives of the Report:

Analysis and estimation of the Tumor Genomics market size and share for the projected period of 2020-2027

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Tumor Genomics market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Read More: https://www.emergenresearch.com/industry-report/tumor-genomics-market

Related Reports:

Desktop 3D Printer Market:https://www.emergenresearch.com/industry-report/desktop-3d-printer-market

LED Emergency Lighting Market: https://www.emergenresearch.com/industry-report/led-emergency-lighting-market

Human Centric Lighting Market: https://www.emergenresearch.com/industry-report/human-centric-lighting-market

Beacon Technology Market: https://www.emergenresearch.com/industry-report/beacon-technology-market

Solar LED Street Lighting Market: https://www.emergenresearch.com/industry-report/solar-led-street-lighting-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalnt in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn